Mid-term objective results of a randomized clinical trial: Fractional carbon dioxide vs sham laser for genitourinary syndrome of menopause on breast cancer survivors using aromatase inhibitors
European Journal of Cancer · 2026-03 · 237 · 116332
DOI: 10.1016/j.ejca.2026.116332 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von E. Mension und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mension, E., Immaculada, A., Laura, R., Natalia, C., Silvia, A., Sonia, A., & Camil, C. (2026). Mid-term objective results of a randomized clinical trial: Fractional carbon dioxide vs sham laser for genitourinary syndrome of menopause on breast cancer survivors using aromatase inhibitors. European Journal of Cancer, 237, 116332. https://doi.org/10.1016/j.ejca.2026.116332
Vancouver
Mension E, Immaculada A, Laura R, Natalia C, Silvia A, Sonia A, et al. Mid-term objective results of a randomized clinical trial: Fractional carbon dioxide vs sham laser for genitourinary syndrome of menopause on breast cancer survivors using aromatase inhibitors. European Journal of Cancer. 2026;237:116332. doi:10.1016/j.ejca.2026.116332
BibTeX
@article{Mension2026,
author = {Mension, E. and Immaculada, A. and Laura, R.T. and Natalia, C. and Silvia, A. and Sonia, A.A. and Camil, C.B.},
title = {Mid-term objective results of a randomized clinical trial: Fractional carbon dioxide vs sham laser for genitourinary syndrome of menopause on breast cancer survivors using aromatase inhibitors},
journal = {European Journal of Cancer},
year = {2026},
volume = {237},
pages = {116332},
doi = {10.1016/j.ejca.2026.116332}
}
EUVIMED